Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Merck
Queensland Health
Chubb
Cipla
US Department of Justice
QuintilesIMS
AstraZeneca
Medtronic
Dow

Generated: August 21, 2017

DrugPatentWatch Database Preview

TEMARIL Drug Profile

« Back to Dashboard

What is the patent landscape for Temaril, and when can generic versions of Temaril launch?

Temaril is a drug marketed by Allergan Herbert and is included in one NDA.

The generic ingredient in TEMARIL is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.

Summary for Tradename: TEMARIL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list17
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TEMARIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Herbert
TEMARIL
trimeprazine tartrate
CAPSULE, EXTENDED RELEASE;ORAL011316-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Allergan Herbert
TEMARIL
trimeprazine tartrate
SYRUP;ORAL011316-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Allergan Herbert
TEMARIL
trimeprazine tartrate
TABLET;ORAL011316-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
Harvard Business School
Novartis
Boehringer Ingelheim
Citi
Daiichi Sankyo
UBS
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot